• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过使用生存素启动子控制腺病毒E1a和E4基因表达来开发用于膀胱癌的具有复制能力的腺病毒。

Development of replication-competent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoter.

作者信息

Seo Ho Kyung, Seo Jeong Bin, Nam Jae-Kook, Jeong Kyung-Chae, Shin Seung-Pil, Kim In-Hoo, Lee Sang Don, Lee Sang-Jin

机构信息

Center for Prostate Cancer, Gyeonggi-do, Biomedical Research Institute, Pusan National University and Research Institute for Convergence of Biomedical Science and Technology, Pusan.

Pusan National University and Biomedical Research Institute, Pusan National University and Research Institute for Convergence of Biomedical Science and Technology, Pusan.

出版信息

Oncotarget. 2014 Jul 30;5(14):5615-23. doi: 10.18632/oncotarget.2151.

DOI:10.18632/oncotarget.2151
PMID:25015402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4170600/
Abstract

Survivin is a member of the inhibitors of apoptosis protein family. Here, we examined survivin expression and confirmed abundant survivin expression in bladder cancer cells. This expression pattern indicated that the transcriptional regulatory elements that control survivin expression could be utilized to discriminate cancer from normal cells. We therefore generated a novel adenovirus termed Ad5/35E1apsurvivinE4 with the following characteristics: 1) E1A and E4 protein expression was dependent on survivin promoter activity; 2) the green fluorescence protein gene was inserted into the genome under the control of the CMV promoter; 3) most of the E3 sequences were deleted, but the construct was still capable of expressing the adenovirus death protein with potent cytotoxic effects; and 4) the fiber knob was from serotype 35 adenovirus. As expected from the abundant survivin expression observed in bladder cancer cells, Ad5/35E1apsurvivinE4 replicated better in cancer cells than in normal cells by a factor of 106 to 102. Likewise, Ad5/35E1apsurvivinE4 exerted greater cytotoxic effects on all bladder cancer cell lines tested. Importantly, Ad5/35E1apsurvivinE4 inhibited the growth of Ku7-Luc orthotopic xenografts in nude mice. Taken together, Ad5/35E1apsurvivinE4 indicates that the survivin promoter may be utilized for the development of a replication-competent adenovirus to target bladder cancers.

摘要

生存素是凋亡抑制蛋白家族的成员之一。在此,我们检测了生存素的表达,并证实其在膀胱癌细胞中大量表达。这种表达模式表明,控制生存素表达的转录调控元件可用于区分癌细胞与正常细胞。因此,我们构建了一种新型腺病毒,命名为Ad5/35E1apsurvivinE4,其具有以下特点:1)E1A和E4蛋白的表达依赖于生存素启动子活性;2)绿色荧光蛋白基因在巨细胞病毒启动子的控制下插入基因组;3)大部分E3序列被删除,但该构建体仍能表达具有强大细胞毒性作用的腺病毒死亡蛋白;4)纤维结来自35型腺病毒。正如在膀胱癌细胞中观察到的大量生存素表达所预期的那样,Ad5/35E1apsurvivinE4在癌细胞中的复制能力比在正常细胞中强106至102倍。同样,Ad5/35E1apsurvivinE4对所有测试的膀胱癌细胞系都具有更强的细胞毒性作用。重要的是,Ad5/35E1apsurvivinE4抑制了裸鼠体内Ku7-Luc原位异种移植物的生长。综上所述,Ad5/35E1apsurvivinE4表明生存素启动子可用于开发一种有复制能力的腺病毒来靶向膀胱癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/cff1b2f7967c/oncotarget-05-5615-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/d8d7044cb842/oncotarget-05-5615-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/1385276abbb5/oncotarget-05-5615-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/bd085c044692/oncotarget-05-5615-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/8f981520a50b/oncotarget-05-5615-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/5f41e9951882/oncotarget-05-5615-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/cff1b2f7967c/oncotarget-05-5615-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/d8d7044cb842/oncotarget-05-5615-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/1385276abbb5/oncotarget-05-5615-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/bd085c044692/oncotarget-05-5615-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/8f981520a50b/oncotarget-05-5615-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/5f41e9951882/oncotarget-05-5615-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/4170600/cff1b2f7967c/oncotarget-05-5615-g006a.jpg

相似文献

1
Development of replication-competent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoter.通过使用生存素启动子控制腺病毒E1a和E4基因表达来开发用于膀胱癌的具有复制能力的腺病毒。
Oncotarget. 2014 Jul 30;5(14):5615-23. doi: 10.18632/oncotarget.2151.
2
Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice.膀胱癌特异性重组溶瘤腺病毒在裸鼠皮下异种移植肿瘤模型中的分布与安全性评估。
Curr Gene Ther. 2012 Apr 1;12(2):67-76. doi: 10.2174/156652312800099599.
3
Overexpression of tumor suppressor TSLC1 by a survivin-regulated oncolytic adenovirus significantly inhibits hepatocellular carcinoma growth.肿瘤抑制因子 TSLC1 的过表达被生存素调控的溶瘤腺病毒显著抑制肝癌的生长。
J Cancer Res Clin Oncol. 2012 Apr;138(4):657-70. doi: 10.1007/s00432-011-1138-2. Epub 2012 Jan 12.
4
A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.一种survivin介导的溶瘤腺病毒可诱导肺癌细胞发生非凋亡性细胞死亡,并在体内显示出抗肿瘤潜力。
J Gene Med. 2006 Oct;8(10):1232-42. doi: 10.1002/jgm.953.
5
A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.一种衣壳修饰的、条件性复制的表达TRAIL的溶瘤腺病毒载体在人胶质母细胞瘤模型中导致增强的癌细胞杀伤作用。
Cancer Res. 2007 Sep 15;67(18):8783-90. doi: 10.1158/0008-5472.CAN-07-0357.
6
A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.一种通过CD46靶向的新型膀胱癌特异性溶瘤腺病毒及其与顺铂联合对CAR阴性表达癌细胞的作用。
Virol J. 2017 Aug 8;14(1):149. doi: 10.1186/s12985-017-0818-1.
7
Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication.生存素反应性条件复制腺病毒表现出癌症特异性且高效的病毒复制。
Cancer Res. 2005 Jun 15;65(12):5284-91. doi: 10.1158/0008-5472.CAN-04-2657.
8
A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.一种肝细胞癌特异性腺病毒变体CV890,与阿霉素联合使用可消除远处的人类肝脏肿瘤。
Cancer Res. 2001 Sep 1;61(17):6428-36.
9
Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.依托泊苷通过自上调多药耐药蛋白1(MDR1)启动子活性增强MDR1驱动的溶瘤腺病毒的抗肿瘤疗效。
Oncotarget. 2015 Nov 10;6(35):38308-26. doi: 10.18632/oncotarget.5702.
10
HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.靶向肝癌的 HCCS1 基因修饰、四重调控溶瘤腺病毒作为一种肿瘤基因病毒治疗策略。
Mol Cancer. 2011 Nov 1;10:133. doi: 10.1186/1476-4598-10-133.

引用本文的文献

1
Tumor-targeted fluorescence labeling systems for cancer diagnosis and treatment.肿瘤靶向荧光标记系统用于癌症的诊断和治疗。
Cancer Sci. 2022 Jun;113(6):1919-1929. doi: 10.1111/cas.15369. Epub 2022 Apr 18.
2
Cell-Surface Integrins and CAR Are Both Essential for Adenovirus Type 5 Transduction of Canine Cells of Lymphocytic Origin.细胞表面整合素和嵌合抗原受体对于5型腺病毒转导淋巴细胞起源的犬类细胞均至关重要。
PLoS One. 2017 Jan 9;12(1):e0169532. doi: 10.1371/journal.pone.0169532. eCollection 2017.
3
Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo.

本文引用的文献

1
Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth.膀胱内灌注 c-MYC 抑制剂 KSI-3716 抑制原位膀胱癌生长。
J Urol. 2014 Feb;191(2):510-8. doi: 10.1016/j.juro.2013.07.019. Epub 2013 Jul 17.
2
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
3
Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy.表达人内皮抑素-血管抑素融合基因的前列腺限制性复制腺病毒具有显著的抗肿瘤功效。
纤维修饰的腺病毒介导的自杀基因疗法能够在体外和体内有效消除膀胱癌细胞。
Oncotarget. 2016 Nov 1;7(44):71710-71717. doi: 10.18632/oncotarget.12324.
4
A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1.一种经典的蛋白激酶A抑制剂通过激活环磷酸腺苷直接激活的交换蛋白1来增强M1病毒的溶瘤效果。
Oncotarget. 2016 Jul 26;7(30):48443-48455. doi: 10.18632/oncotarget.10305.
5
Trial Watch-Oncolytic viruses and cancer therapy.试验观察——溶瘤病毒与癌症治疗
Oncoimmunology. 2015 Dec 8;5(2):e1117740. doi: 10.1080/2162402X.2015.1117740. eCollection 2016 Feb.
6
Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy.腺病毒介导的泛素连接酶RNF8下调使膀胱癌对放疗敏感。
Oncotarget. 2016 Feb 23;7(8):8956-67. doi: 10.18632/oncotarget.6909.
7
Targeted therapies in bladder cancer: an overview of in vivo research.膀胱癌的靶向治疗:体内研究概述。
Nat Rev Urol. 2015 Dec;12(12):681-94. doi: 10.1038/nrurol.2015.231. Epub 2015 Sep 22.
8
RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells.RGD修饰的溶瘤腺病毒对CAR阴性的膀胱癌起始细胞表现出强大的细胞毒性作用。
Cell Death Dis. 2015 May 14;6(5):e1760. doi: 10.1038/cddis.2015.128.
Clin Cancer Res. 2008 Jan 1;14(1):291-9. doi: 10.1158/1078-0432.CCR-07-0867.
4
Oncolytic viral therapy by bladder instillation using an E1A, E1B double-restricted adenovirus in an orthotopic bladder cancer model.在原位膀胱癌模型中,使用E1A、E1B双限制腺病毒通过膀胱灌注进行溶瘤病毒治疗。
Urology. 2006 Sep;68(3):674-81. doi: 10.1016/j.urology.2006.04.021. Epub 2006 Sep 18.
5
Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model.条件性复制腺病毒介导的膀胱癌基因治疗:原位体内模型
Urol Oncol. 2006 Jul-Aug;24(4):362-71. doi: 10.1016/j.urolonc.2005.11.028.
6
The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma.人存活素启动子:一种治疗神经胶质瘤的新型转录靶向策略。
J Neurosurg. 2006 Apr;104(4):583-92. doi: 10.3171/jns.2006.104.4.583.
7
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.使用欧洲癌症研究与治疗组织(EORTC)风险表预测Ta T1期膀胱癌个体患者的复发和进展:来自七项EORTC试验的2596例患者的综合分析
Eur Urol. 2006 Mar;49(3):466-5; discussion 475-7. doi: 10.1016/j.eururo.2005.12.031. Epub 2006 Jan 17.
8
CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor--armed oncolytic adenovirus for the treatment of bladder cancer.CG0070,一种条件性复制的粒细胞巨噬细胞集落刺激因子武装的溶瘤腺病毒,用于治疗膀胱癌。
Clin Cancer Res. 2006 Jan 1;12(1):305-13. doi: 10.1158/1078-0432.CCR-05-1059.
9
Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication.生存素反应性条件复制腺病毒表现出癌症特异性且高效的病毒复制。
Cancer Res. 2005 Jun 15;65(12):5284-91. doi: 10.1158/0008-5472.CAN-04-2657.
10
A survivin gene signature predicts aggressive tumor behavior.生存素基因特征可预测肿瘤的侵袭性行为。
Cancer Res. 2005 May 1;65(9):3531-4. doi: 10.1158/0008-5472.CAN-04-4284.